Barclays »

Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Barclays

Quarter-by-quarter ownership of Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Mirum Pharmaceuticals Inc Note 4.000 5/0

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals Inc Note 4.000 5/0 held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals Inc Note 4.000 5/0 by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $860k 358k 2.40
2025-06-30 $617k 348k 1.77

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0

Deerfield Management Company
Readystate Asset Management
MacKay Shields
Tenor Capital Management
Citadel Advisors
Franklin Resources
Polar Securities
Capstone Investment Advisors
Bnp Paribas Arbitrage, Snc
Point72 Asset Management
FMR
Aristeia Capital
Aequim Alternative Investments
SSI Investment Management
Lord, Abbett & Co

View all funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0